首页> 外文会议>International Conference on Applied Science, Engineering and Technology >Expression Level of Serum FGF-21 in Patients with Hypothyroidism and Correlation Analysis of Biochemical Indexes
【24h】

Expression Level of Serum FGF-21 in Patients with Hypothyroidism and Correlation Analysis of Biochemical Indexes

机译:血清FGF-21在甲状腺功能减退症患者中的表达水平及生化指标的相关分析

获取原文

摘要

Objective: To explore the expression level and correlation analysis of fibroblast growth factor 21 (FGF-21) and its biochemical indexes in serum of patients with hypothyroidism. Method: To collect 168 cases of patients in the Affiliated Hospital of Beihua University, 62 cases of hyperthyroidism group, 52 cases of hypothyroidism group, 54 cases of healthy group, which are adopted respectively by enzyme-linked immunosorbent assay (ELISA) detection of FGF-21; chemiluminescence detection of thyroid stimulating hormone (TSH), serum free triiodothyronine (FT3), free thyroxine (FT4); detection of, biochemical analyzer of total cholesterol (TC) and triglyceride (TG), low density lipoprotein (LDL), as well as high density lipoprotein (HDL) and other indicators. Results: ① The amount of FGF-21, TSH, TC, TG and LDL of serum in hypothyroidism group is significantly higher than that in control group (P<0.05), the amount of FT3, FT4 and HDL of serum in free thyroxine is significantly lower than that in control group (P<0.05). The amount of FGF-21, TSH, TC, TG and LDL of serum in hyperthyroidism group is significantly lower than that in control group (P<0.05), the amount of FT3, FT4 and HDL of serum in free thyroxine is significantly higher than that in control group (P<0.05); ②Through the correlation analysis between plasma FGF-21, the level of plasma FGF-21 in patient with hypothyroidism is positively correlated with age, gender, TSH, TC, LDL. Conclusion: The level of serum FGF-21 is increased in hypothyroidism patients, which is correlated with TSH, TC, TG and LDL, etc. which may be the risk factors for thyroid dysfunction and result in the development of disease. The elevation of TC, TG and LDL in patients with hypothyroidism may also be one of the main causes of dyslipidemia.
机译:目的:研究的成纤维细胞生长因子21(FGF-21)和在患有甲状腺功能减退血清其生化指标的表达水平和相关性分析。方法:收集168案件患者在北华大学附属医院62例甲亢组52例,甲状腺功能减退症组的54例健康对照组,其由酶联免疫吸附测定法分别通过的(ELISA)检测FGF的-21;化学发光检测促甲状腺激素的(TSH),血清游离T3(FT3),游离甲状腺素(FT4);检测的,生化分析仪总胆固醇(TC),甘油三酯(TG),低密度脂蛋白(LDL)的,以及高密度脂蛋白(HDL)等指标。结果:①FGF-21的量,TSH,TC,TG和甲减组血清的LDL比显著高于对照组(P <0.05),血清FT3,FT4和HDL的游离甲状腺素的量为低于对照组(P <0.05)降低显著。 FGF-21,TSH,TC,TG的使用量和甲状腺功能亢进症组的血清的LDL是显著低于对照组(P <0.05),FT3,FT4和游离甲状腺素的血清HDL的量显著高于于对照组(P <0.05); ②经由等离子体FGF-21之间的相关性分析,等离子体FGF-21与甲状腺功能减退症患者的水平与年龄,性别,TSH,TC,LDL相关。结论:血清FGF-21的水平在甲状腺机能减退患者,其与TSH,TC,TG和LDL等相关,其可以是用于在疾病的发展甲状腺功能障碍和结果的危险因素增加。 TC,TG和LDL的甲减患者的高度也可能是血脂异常的主要原因之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号